Category: llnlugaf

first_imgArts & Culture | JuneauJuneau makes top 10 list for most ‘arts vibrant’ small communitiesApril 28, 2017 by Jeremy Hsieh, KTOO Share:Juneau made a top 10 list for most “arts vibrant” small communities. That’s communities with a population under 100,000.“We were thrilled!” said Meghan Chambers, an executive assistant at Juneau Arts and Humanities Council. “I mean, the word vibrant is already in our branding, so that’s helpful for us.”The National Center for Arts Research at Southern Methodist University in Dallas published the data-driven list earlier this month. Juneau’s No. 8 ranking out of 937 communities is based on 12 per capita measures, includingThe number of people employed by arts and culture institutions,The number of nonprofit arts and cultural organizations in the area,Revenue and expenses of those institutions, andState and federal funding of the arts.The No. 1 community was Breckenridge, Colorado.“To be ranked No. 8 on the vibrant list … is really exciting and proves that we’ve been working really hard and our efforts are seen nationally,” Chambers said.Across the metrics, Juneau was No. 1 in one area: federal arts grant dollars per capita. That could become moot in the next ranking if President Donald Trump’s proposed federal budget goes through. He’s proposed eliminating the National Endowment for the Arts and the National Endowment for the Humanities.Share this story:last_img read more

first_imgJuneau | Public Safety | SoutheastNo tsunami danger after 5.0 quake in British ColumbiaSeptember 16, 2017 by Tripp J Crouse, KTOO Share:A screen capture from the National Weather Service website shows where a 5.0-magnitude earthquake struck on Saturday. The National Tsunami Warning Center in Palmer said it wouldn’t trigger a tsunami.About 3:30 p.m. Saturday, Juneau residents may have felt little more than a slight shake.That’s because a 5.0 magnitude earthquake near Kelsall Lake, British Columbia, which is about 60 miles northwest of Haines, struck at a depth of 3 miles.Dave Nanney has owned and operated the Chilkat Eagle Bed and Breakfast for almost 20 years in Haines. He said at first, it felt like a heavy equipment driving by.“Sometimes the big machines rumble, and it feels like a tremor,” Nanney said. “It was very subtle.”He said there were about three shocks.According to the National Tsunami Warning Center in Palmer, a quake of that size isn’t going to make a tsunami.“It’s just not nearly big enough, even though we got reports as far away as Juneau that it was felt,” said Chris Popham, a senior tsunami specialist with the National Tsunami Warning Center.A quake would need to be significantly larger and closer to the coast to trigger a tsunami warning.“We’d be issuing a warning for a 7.1 , but for a 5.1, 5.0 or so that’s a thousand times less energy,” Popham said. “This quake would have needed to be a thousand times bigger – and honestly it would have needed to be a lot closer to the coast to issue a warning.”Popham said a 7.0 would need to be within about 30 miles of the coast for the center to issue a warning. Today’s earthquake was too far away and far too weak for a warning.Share this story:last_img read more

first_img Caitlin Morrison Share whatsapp More From Our Partners Supermodel Anne Vyalitsyna claims income drop, pushes for child supportnypost.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgFlorida woman allegedly crashes children’s birthday party, rapes teennypost.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgA ProPublica investigation has caused outrage in the U.S. this weekvaluewalk.comBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.org980-foot skyscraper sways in China, prompting panic and evacuationsnypost.comI blew off Adam Sandler 22 years ago — and it’s my biggest regretnypost.comBiden received funds from top Russia lobbyist before Nord Stream 2‘Neighbor from hell’ faces new charges after scaring off home buyersnypost.comMark Eaton, former NBA All-Star, dead at 64nypost.comKiller drone ‘hunted down a human target’ without being told tonypost.comKamala Harris keeps list of reporters who don’t ‘understand’ her: reportnypost.comWhy people are finding dryer sheets in their mailboxesnypost.comInside Ashton Kutcher and Mila Kunis’ not-so-average farmhouse estatenypost.comUK teen died on school trip after teachers allegedly refused her Ovo Energy to launch second partner project INDEPENDENT energy supplier Ovo is continuing to put pressure on the big six with its second community partnership, this time in Sussex.The firm is partnering with Community Energy South to launch the Sussex Energy Tariff in the spring of 2015. According to Ovo, the project could save residents up to £200 a year off their energy bills. Ovo revealed plans for its first partnership in Plymouth in early October. Energy and climate change minister Amber Rudd, who will attend today’s launch event, said: “Community energy partnerships really do put the power in people’s hands.” Monday 10 November 2014 12:03 am Show Comments ▼ whatsapp Tags: NULLlast_img read more

first_img Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Log In | Learn More What’s included? Barbara Schaal, president of the American Association for the Advancement of Science. Alissa Ambrose/STAT By Stephanie Simon Feb. 15, 2017 Reprints The big research initiatives launched by President Barack Obama should have enough momentum to keep rolling in the coming years, even if President Donald Trump doesn’t prioritize them, leading advocates for science said Wednesday.Obama, a self-described “science geek,” announced the BRAIN Initiative, which aims to dive down to the cellular level to understand the workings of the human brain, in 2013. The Precision Medicine Initiative came two years later; it seeks to collect detailed health data from at least a million volunteers to fuel research on a variety of diseases. Both projects are housed in the National Institutes of Health. In the Lab Obama’s ‘big science’ initiatives will keep rolling under Trump, AAAS leaders predict STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED What is it? GET STARTED Tags mental healthpolicyresearchWhite Houselast_img read more

Who will pay for CRISPR?

first_imgFirst OpinionWho will pay for CRISPR? CRISPR will allow us to alter our existing genes. But it often relies on using viruses to shuttle the molecular gene-editing systems into our cells, and can be as expensive as other gene therapies.Editas Medicine plans to use CRISPR-Cas9 to treat various diseases, including Leber congenital amaurosis. “Enthusiasm is great for interventions in the eye,” New York University bioethicist Arthur Caplan told me. “They permit trying one eye at a time and it is easy to tell if anything positive happens. Safety is much easier to ensure.” But in its annual report, Editas noted “significant uncertainty” on whether payers would cover the treatment. In fact, a handful of insurance companies (VantageBlue from Blue Cross Blue Shield of Rhode Island, Select Health, and VIVA Health) have issued policy documents that exclude gene therapy from coverage, a move that experts say establishes policy against paying for CRISPR-based therapeutics.The Institute for Clinical and Economic Review released a report in March stating there are 12 to 14 gene therapy candidates that are expected to be among the first for commercial approval. “With payer budgets already stretched, and reining in the costs high on the agenda, both public and private payers will likely balk at the cost of some of these gene-based treatments,” the American Journal of Managed Care wrote in a reflection on the report. “Europe has the lead in approved gene therapies, and the first such drug to be approved had a launch price of $1.4 million. Can the US health care system absorb the cumulative impact of such prices, considering that 10 percent of the population has a rare condition linked to a genetic defect?”Five major gene therapy companies went public last year, suggesting that investors are ready to bet on the commercial prospects. Editas signed a deal with Juno Therapeutics that could be worth up to $737 million. The companies would combine CRISPR with other tactics to trick the immune system’s T cells to fight cancer. Those tactics could include disabling genes in T cells that prevent cancer cells from shutting down a T cell response, and adding bits of genetic code to engineer new receptors into T cells to let them attach to abnormal proteins in cancer cells called neoantigens.Gene and cell therapies that run into the six figures and beyond are poised to heighten the cost of cancer treatments, which not everyone may be able to afford. In fact, oncologist Dr. Siddhartha Mukherjee, author of the bestselling “Emperor of All Maladies,” gave a speech this month at the annual American Society of Clinical Oncology meeting that warned about dividing the world “into the rich who can afford personalized cancer treatment and the poor who cannot.” A few years ago, Dutch drug company uniQure set up a plant in Lexington, Mass., to make a gene therapy called Glybera, at the time the most expensive drug in the world. It used viruses to slip copies of a gene into human cells to restore an enzyme needed to break down fats. The cost? $1.4 million per patient. The company eventually abandoned its bid to bring Glybera to the U.S. and, after having sold it just once in Germany, recently withdrew it from European markets, rendering it a commercial failure.Spark Therapeutics of Philadelphia is vying to bring the first gene therapy to market in the U.S. to treat a rare genetic eye disease called Leber congenital amaurosis 2. Analysts said it could cost a half-million dollars per eye. Like Glybera, Spark’s treatment is a form of traditional gene therapy, which makes use of viruses to get bits of restorative code into our cells.advertisement The ruckus over the CRISPR gene-editing system hides a dark reality: its high cost may make it unaffordable and questions remain whether most insurance companies will pay for it.As CRISPR begins to move forward in clinical trials, there are some signals about how it may — or may not — be received commercially. Other types of gene therapies carry a price tag that is likely to induce sticker shock. If adopted, these therapies will add striking new cost burdens to our health care system.“The cost isn’t coming down,” said Mark Trusheim, director of the Massachusetts Institute of Technology’s NEW Drug Development Paradigms, a think tank working on the problem of how we will pay for expensive new drugs. “Companies will say, ‘We are developing these medicines, just pay us’; insurers will say, ‘We can’t afford it.’”advertisement NewslettersSign up for The Readout Your daily guide to what’s happening in biotech. Orkin and Reilly also like the idea of using U.S. government funds from the Orphan Drug Act, established in 1983, to pay gene therapy companies for their commercial products. Another idea for keeping gene therapy, including CRISPR-based therapies, affordable is that investors could ask insurance companies to buy in bulk. MIT’s Ernst Berndt, inspired in part by volume purchases of vaccines in Africa, has proposed “advanced market commitments” through which insurance groups commit to buying a bunch of expensive drugs. That model that could be applied to gene therapies, but the insurers may not go for it without a bit more give.In 2009, the Biologics Price Competition and Innovation Act created a pathway for approving generic biologics, also known as biosimilars. It may apply to CRISPR-based biosimilars, but generic gene-editing — and thus competition to drive down prices — is unlikely to appear for decades. Cathryn Donaldson, a spokesperson for American’s Health Insurance Plans, noted that a lack of generic forms of CRISPR means “drug makers may charge whatever they want for their branded medication. “In 1968, Garrett Hardin argued in his now-classic essay, “The Tragedy of the Commons,” that a shared-resource system will tend to be depleted by self-interested individuals. He also argued against exponential growth — to which we could add today the growth of biotech valuation.Health care is a limited shared resource, and expensive new technologies could add pressures resulting in unequal access, especially to cancer therapies. Given the aggressive drive for money, and without new approaches in thinking, we are headed for disaster. One of two things will happen: either we will embrace a national health care system with broad access but that severely limits expensive new drugs, gene therapies, and CRISPR-based biologics; or these treatments will be available to only the wealthiest among us who can pay for them, a dystopian vision which is perverse but perhaps more realistic considering the pressures for a return on investment.Writer Jim Kozubek is the author of “Modern Prometheus: Editing the Human Genome with Crispr-Cas9,” published by the Cambridge University Press. Privacy Policy [email protected] APStock Please enter a valid email address. Leave this field empty if you’re human: Tania Bubela, a law and policy expert, and Chris McCabe, a health economist, both at the University of Alberta, will be holding a workshop in late June in Banff, Canada, to explore how to enable access to high-priced technologies. According to Bubela, gene-editing systems such as CRISPR-Cas9 promise to heighten the tension around health care policy. One idea for easing the tension is for regulators to permit drug makers to get reimbursed from insurers before their gene therapy gets FDA approval, while requiring drug makers to collect more data before charging full price — a kind of price control.“Companies will charge whatever the market will bear,” Bubela told me. “I’m not even sure that many of these gene therapies will work, and not all medicine is worth the price.” But if these technologies become broadly used, especially in altering T cells for cancer, payers won’t meet the demands of steep prices, and Bubela predicts that “the system implodes under its own weight.”I believe that part of the problem lies in financial dealings. The Broad Institute, for instance, holds patents to gene editing tools such as CRISPR-Cas9 and CRISPR-Cpf1 and has issued exclusive licenses to Editas to use these tools for medical purposes. It could issue more-affordable CRISPR licenses one gene at a time, say directly to Juno Therapeutics, which now accesses them through its multimillion dollar deals with Editas. But that would cut Editas investors out of the loop. Such deals tend to inflate drug prices, since venture and public investors in Editas demand a cut on each CRISPR application. As investors engage in layers of transactional deals along the top of the food chain, the costs of gene therapies go up while the financiers may shift blame for a lack of patient coverage to insurance companies.Dr. Stuart Orkin, a pediatric oncologist at Boston Children’s Center, and Dr. Philip Reilly, a partner at Third Rock Ventures, an Editas funder, coauthored a paper in Science magazine saying that sticker shock shouldn’t halt commercialization. It can cost $300,000 a year to treat a single hemophilia patient with existing standard treatments and $25,000 to treat a single sickle-cell patient. Given costs like those, one-time gene therapy treatments running into the six figures may be comparatively affordable if an insurer makes payments to a drug-maker over a decade that are tied to the drug’s continued performance. In fact, the idea of spreading payments over years as annuities originated with corporate-friendly FDA commissioner Scott Gottlieb in a 2014 paper he co-authored for the American Enterprise Institute.Other performance-based models are being tested. GlaxoSmithKline, for example, is trying to bring a $665,000 gene therapy to the U.S. to treat an immune system disorder. The company said it will tie the cost of the drug to its performance in patients — with a money-back guarantee. “The reality is it’s very tough, and it doesn’t come easy,” said Jonathan Appleby, a chief scientific officer for the company’s rare disease unit. By Jim Kozubek June 26, 2017 Reprints Related: Broad Institute prevails in heated dispute over CRISPR patents About the Author Reprints Do CRISPR enthusiasts have their head in the sand about the safety of gene editing? Jim Kozubek Tags cancerCRISPRpharmaceuticals Related:last_img read more

first_imgHome GAA Camogie In Pictures: Joyous scenes as O’Moore’s claim third Laois camogie title in… GAACamogieSport Pinterest SEE ALSO – Shock specialists Rosenallis beat Borris-Kilcotton to top their group in Laois SHC Facebook Twitter Pinterest WhatsApp Electric Picnic News Twitter WhatsApp Previous articleAll the recent job vacancies, as advertised on LaoisTodayNext articleSustainability and Leaving Cert Results – a busy time in Portlaoise College LaoisToday Reporter center_img Electric Picnic organisers release statement following confirmation of new festival date Electric Picnic RELATED ARTICLESMORE FROM AUTHOR Laois Councillor ‘amazed’ at Electric Picnic decision to apply for later date for 2021 festival Bizarre situation as Ben Brennan breaks up Fianna Fáil-Fine Gael arrangement to take Graiguecullen-Portarlington vice-chair role Facebook By LaoisToday Reporter – 13th September 2020 For the third time in five years, O’Moore’s are Laois camogie champions.That’s some going for a club that prior to 2016 had never even won it once.But in a thrilling final in MW Hire O’Moore Park on Saturday, they saw off the brave challenge of St Brigid’s to win 0-15 to 0-10.In an unusual year, it was an unusual finale; the biggest game of the season played behind closed doors, though live streamed on the Laois Camogie Facebook page for those who couldn’t attend.St Brigid’s, seeking a first title since 2004 and keen to end their losing streak in finals, arrived to the decider unbeaten.But O’Moore’s had beaten champions semi-final and despite indifferent form in the group stages, they had plenty of quality and experience throughout their team.And so it proved as they came back from a half-time deficit to claim glory, the latest success under manager Dermot McGill.Afterwards captain Alison McEvoy was presented with the trophy by Laois Camogie chairman Barney O’Connor while Laura Marie Maher was honoured as the LaoisToday ‘Player of the Match’ and presented with her prize by Alan Hartnett.Photographer Joe Bermingham was on hand to capture a selection of images afterwards. TAGSLaois CamogieO’Moore’sSt Brigid’s In Pictures: Joyous scenes as O’Moore’s claim third Laois camogie title in five yearslast_img read more

first_imgPublished: Sept. 25, 2020 • By Katie Hogan Failure. This one, single word throws us off so much. Just the sight and sound of it makes many of us want to flinch and run the other direction. However, that’s the problem. We shouldn’t be scared of failure – instead, we should embrace it. Everyone experiences failure at some point in their lifetime. It is perfectly okay and normal, and there is nothing to be afraid of or to get upset about! Here are some helpful tips on how to cope and deal with failure. Remember: You’re not a failure just because you had a setback We will all experience setbacks in life – whether it’s getting a bad grade on a test, not landing a job that you interviewed for, messing up in a presentation or forgetting a friend’s birthday. These things are all a part of living and being human. When we have a setback, it is easy to start thinking that we will always fail in that area of our life. Then it starts to get into our heads that we are failures. However, we need to remind ourselves that just because we got one bad grade on a test or didn’t get the internship we were hoping for, that doesn’t mean we will do it again tomorrow. Which brings us to my next point: failure is a learning experience. Failure is a learning experienceWhen there’s a setback, try asking yourself the following:What’s one thing that I can learn from this? How can I avoid making the same mistake again? What can I do differently next time? We use failure to learn and to grow. We can use our mistakes, such as procrastinating on a project and then getting a bad grade on it, to do better next time. Usually the feeling of getting a bad grade reminds us that we do not want it to happen again, so we treat it as a learning experience. If we chose not to learn from our mistakes, then the same failures will continue to happen over and over again. Many people see failure as a terrible thing, when really it is valuable feedback for something that we can improve. Accept how you feel When we fail, we may feel anger, embarrassment, sadness or even frustration. Sometimes the emotions may be stronger for some than others. That is okay. Pushing failure away by distracting yourself, or covering it up with a smile will only make it worse. It is best to just accept the feeling because in the long run it will be easier to move on.Celebrate your successesJunior year I received a bad grade in a class. I studied very hard for the final because I knew it was going to be difficult, but I still did not do well. All of my other final grades turned out to be amazing. However, when my dad congratulated me on my grades, I said “what’s there to be proud of?”, because I was only focused on the single bad grade. My dad reassured me not to be too hard on myself and to enjoy my successes. He is correct. When we fail, it’s important to keep things in perspective. Remember to celebrate your accomplishments, and rather than dwelling on the failure, use it to change things, make them better in the future and move forward. Everyone fails We mostly only hear about people’s successes. However, the road to these successes tends to have many setbacks. Michael Jordan summed it up with this quote: “I’ve missed more than 9,000 shots in my career. I’ve lost almost 300 games. 26 times, I’ve been trusted to take the game winning shot and missed. I’ve failed over and over and over again in my life. And that is why I succeed.”We must embrace our failures, and along the way they will lead to our success. Remember that it is okay to fail! We are not perfect, we are human.last_img read more

first_imgAdvertisements RelatedWeapons Left with Police for Extended Period will be destroyed – Bunting By Alecia Smith-Edwards, JIS Reporter RelatedWeapons Left with Police for Extended Period will be destroyed – Bunting RelatedWeapons Left with Police for Extended Period will be destroyed – Bunting Weapons Left with Police for Extended Period will be destroyed – Bunting National SecurityFebruary 8, 2012 FacebookTwitterWhatsAppEmail Licensed firearm holders are being reminded that weapons left in the care of the police over a protracted period, will be destroyed. The reminder came from the Minister of National Security, Hon. Peter Bunting, on Tuesday Feb. 7, as he addressed the start of a weapons destruction exercise at the Jamaica Constabulary Forces’ (JCF) Armoury on Elletson Road, Kingston. “I suspect that many of those holders have migrated; some may even have died. The approach we are taking and which is allowed under our (Firearms) Act is that if they are not retrieved within a certain period of time…we are going to dispose of them,” he warned. The Minister said that the process has already started “and it is going to be accelerated in the months to come”. In the meantime, Mr. Bunting said that the audit being conducted by the Firearm Licensing Authority (FLA) on the stockpile of weapons at the JCF has to be accelerated, so too the rate of destruction. “We have to get this done within the short-term. Similarly, the recertification of licensed firearm holders (about) 30,000 persons, cannot continue at the pace at which it is going. It has to be accelerated to get it done in a year or two,” he said. He said these actions will greatly assist the police in solving crime, “because part of the recertification process (involves getting) the ballistic footprints of all the weapons that are held by all licensed firearm holders”. Approximately 2,000 guns were disposed of today at the Carib Cement Company facility in Rockfort, while half a tonne of ammunition will be destroyed tomorrow (February 8) at the Jamaica Police Academy at Twickenham Park, St. Catherine. The firearms, which are from the JCF and the FLA, are being destroyed as they are either unserviceable, obsolete, or recovered by law enforcement personnel. Some are civilian firearms that were left in the care of the police over an extended period. The exercise falls under the United Nations Regional Centre for Peace, Disarmament and Development in Latin America and the Caribbean’s (UNLIREC) firearm stockpile management and weapons destructionassistance package for Caribbean states. The programme was launched in Jamaica in 2010 to combat the illicit trade in firearm and ammunition; strengthen the capacity of the security forces; and reduce armed violence in Jamaica, and by extension the region.last_img read more

first_imgFSU moot court team wins national title Mar 11, 2020 News in Photos FLORIDA STATE UNIVERSITY COLLEGE OF LAW moot court team has won first place in a national moot court competition. On February 29, FSU Law won the 2020 Domenick L. Gabrielli National Family Law Moot Court Competition held at Albany Law School in New York. This is the fifth time Florida State has won the Gabrielli competition. Twenty-seven law school participated in the competition, including a team from New York University School of Law, which Florida State’s team beat in the final round of competition. Other competing law schools included Northeastern University, Seton Hall University, University of California (Hastings), University of Nevada — Las Vegas, Wake Forest University, and William & Mary. Winning team members are second-year law students Gabriela De Almeida, left, of Jacksonville and Hannah DuShane of Oxford. Barbara Busharis, who is an assistant public defender in Tallahassee and previously taught legal writing at FSU Law, coached the team to victory. “We are extremely proud of our talented student advocates and their dedicated coach,” said Dean Erin O’Connor. “Winning a second national championship in two weeks is extraordinary!” Florida State’s advocacy teams have a strong record of winning competitions. On February 22, FSU Law won the 2020 Jeffrey G. Miller National Environmental Law Moot Court Competition. Since 2010, the Moot Court Team has won first place in 17 national competitions and in one international competition.last_img read more

first_img Diana is Mobile World Live’s US Editor, reporting on infrastructure and spectrum rollouts, regulatory issues, and other carrier news from the US market. Diana came to GSMA from her former role as Editor of Wireless Week and CED Magazine, digital-only… Read more Tags Mobile Mix: Buzzing for Barcelona AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 30 JUN 2020 5GQualcomm GSMA THRIVE CHINA 2020: Qualcomm president Cristiano Amon (pictured) highlighted the potential of 5G to revolutionise society and the economy, noting the Covid-19 (coronavirus) pandemic made clear how the technology could be used to improve education, healthcare, human interaction and industry.In a keynote, Amon said approximately 1.7 billion students around the world shifted to remote study after the pandemic struck, but added not all were able to make the transition due to a lack of connectivity. He argued 5G can help bridge such digital divides going forward, allowing “students worldwide to have high quality content, real-time interactivity, personalised content in a fully immersive experience”.The executive called on operators around the world to join those already offering 5G-enabled PCs, which he called “a very powerful tool” to deliver access and “make sure the next generation is ready for the future society we’re building”.Case closedAmon said 5G will also be key in enabling a shift to remote healthcare, noting predictions more than 1 billion virtual care visits are expected in the US this year and tips half of medical services will be delivered virtually by 2030. Next generation service can enable “richer, more persistent social interaction” through technologies including VR and AR, he argued.“We don’t have to explain any more many of the 5G use cases. It’s very clear its benefits in education, healthcare and social interactions in a time like this.”Underscoring 5G’s global economic potential, Amon pointed to IHS Markit estimates that the technology will have a $13.2 trillion impact by 2035.He noted 3GPP’s forthcoming Release 16 standards will be key to this progress, pushing the technology beyond enhanced mobile broadband to enable new features spanning industrial, mission critical, automotive and other enterprise-oriented use cases.“These new 5G capabilities will open doors to an expanded set of opportunities for the global economy. The impact to virtually every industry will be significant and far reaching.” Subscribe to our daily newsletter Back Nokia scores Philippines 5G deal with Dito Home Qualcomm boss hails 5G fightback against Covid-19center_img Telkomsel turns on 5G in major cities Previous ArticleHuawei chief hails 5G impact on industryNext ArticleChina Telecom looks to SA 5G to fuel quantum leap Author Asia Related Diana Goovaerts last_img read more

Back to top